Proteomic analysis of multiple sclerosis cerebrospinal fluid - Wikidata - awgldk - TriplyDB

Proteomic analysis of multiple sclerosis cerebrospinal fluid

Proteomic analysis of multiple sclerosis cerebrospinal fluid

http://www.wikidata.org/entity/Q28269026

about

Membrane-derived phospholipids control synaptic neurotransmission and plasticity Chitinase 3-like proteins as diagnostic and prognostic biomarkers of multiple sclerosis Novel point mutations attenuate autotaxin activity Quantitative and qualitative differences in protein expression between papillary thyroid carcinoma and normal thyroid tissue.Human body fluid proteome analysis.Electrophoretic separations of cerebrospinal fluid proteins in clinical investigations.Cerebrospinal fluid proteome profile in multiple sclerosis.Quantitative proteomic analysis of the cerebrospinal fluid of patients with multiple sclerosis.Proteome analysis of biomarkers in the cerebrospinal fluid of neuromyelitis optica patients.Novel approaches to detect serum biomarkers for clinical response to interferon-beta treatment in multiple sclerosis.Identification of biomarkers for diagnosis and progression of MS by MALDI-TOF mass spectrometry.Fusion of metabolomics and proteomics data for biomarkers discovery: case study on the experimental autoimmune encephalomyelitis.Plasminogen in cerebrospinal fluid originates from circulating blood.Proteomic pattern analysis discriminates among multiple sclerosis-related disorders.Urethral dysfunction in female mice with estrogen receptor β deficiency.Proteomic analysis of cerebrospinal fluid in a fulminant case of multiple sclerosis.Biomarkers: mining the biofluid proteome.Autotaxin downregulates LPS-induced microglia activation and pro-inflammatory cytokines production.Biomarkers in chronic adult hydrocephalus.Non-cell autonomous and non-catalytic activities of ATX in the developing brain Proteomic analysis of cerebrospinal fluid in canine cervical spondylomyelopathy.Proteomic profile of cerebrospinal fluid in patients with multiple sclerosis using two dimensional gel electrophoresis.Bypassing hazard of housekeeping genes: their evaluation in rat granule neurons treated with cerebrospinal fluid of multiple sclerosis subjects Sera proteomic biomarker profiling in HIV-1 infected subjects with cognitive impairment Treatment of children and adolescents with multiple sclerosis.Development of protein biomarkers in cerebrospinal fluid for secondary progressive multiple sclerosis using selected reaction monitoring mass spectrometry (SRM-MS)Toward biomarkers in multiple sclerosis: new advances.Identification of differentially expressed proteins in experimental autoimmune encephalomyelitis (EAE) by proteomic analysis of the spinal cord.Autotaxin (ATX): a multi-functional and multi-modular protein possessing enzymatic lysoPLD activity and matricellular properties Application of proteomic technology in eye research: a mini review.Modulation of purinergic signaling by NPP-type ectophosphodiesterases.Cerebrospinal fluid biomarkers of neurodegeneration in chronic neurological diseases.Ubiquitin fusion degradation protein 1 as a blood marker for the early diagnosis of ischemic stroke Naturally presented peptides on major histocompatibility complex I and II molecules eluted from central nervous system of multiple sclerosis patients.Proteomic strategies in multiple sclerosis and its animal models Discovery of novel disease-specific and membrane-associated candidate markers in a mouse model of multiple sclerosis.Application of mass spectrometry-based proteomics for biomarker discovery in neurological disorders.Cerebrospinal fluid in multiple sclerosis.The emerging role of vitamin D binding protein in multiple sclerosis.Proteomic profiling of cerebrospinal fluid in Creutzfeldt-Jakob disease.

P2860

Q27347783-6B3F721B-473C-4475-B090-99E6D3AF60B1 Q28257420-EC91E0BA-8779-418D-A61E-1711179F80CD Q30440170-75290D60-3EB3-4343-97D7-F45744E691F9 Q33247421-04A1FAD7-2906-4286-AD49-06E038FF14A7 Q33262623-EE17915D-8DA0-453E-B994-F461A4D2A2F1 Q33282300-66B79DCE-F770-4C58-A530-439D2BDFDE75 Q33299647-8D048EAF-8436-4BAD-92B7-36DCEB6D3F95 Q33481896-FF57FB09-5483-452C-89CA-C1D1AD9A7372 Q33497345-AF8E5897-AEA5-44F4-8DA2-2B3677A9A48A Q33576939-2D8C5606-0C02-433F-8D33-3AAB0E24031F Q33877162-D9B2FBB9-7547-45B7-AF61-1F5341AD3E40 Q33940116-934F961A-F8A6-49EE-AC31-083CFE09C1F4 Q34235404-84D31BE2-B2E2-43E0-AFCD-7ADDB21B2AB5 Q34241223-E8234F7E-5017-4099-AE9A-6C69FAA9A6AE Q34282285-29DD0F20-00E8-4C67-8A12-2F06046B879B Q34353773-208AC1DE-E013-4B47-A589-EAFF387B69BA Q34389937-1937E45F-3CDA-4C65-A0DD-3D82AA8DEBAF Q34764899-CA07384F-169B-4586-8248-63090CC5D9C1 Q35101048-D5E28C87-B6D1-4ACD-B778-476D8F531AD3 Q35145784-8CE039F1-E91F-46A8-AD7D-7C846040682D Q35672528-67D168CE-89AB-4F08-9501-C5FAABB888A6 Q36038317-A7CD4610-C1D2-456A-AF48-68CA3C8D5AD6 Q36098087-C23D2679-AA5C-4D51-9B1C-83B3C6E3F853 Q36121837-D178AA79-D5B4-47A9-8754-555F1258BD3F Q36153390-6BB0C12A-1DE0-4AFE-9157-A6520EB98D58 Q36303187-C72BEF7D-B8E3-436F-86BD-2881BEB4F748 Q36492380-BA19050C-FBCB-421B-9CD9-35EF80B543D9 Q36727013-272D00C0-DEE7-47B6-840D-5974E3C2DB1C Q36930924-1631A428-994D-40DD-AC2D-472A876F6AD8 Q37018105-65645319-32A8-4C3B-962C-A09DB202AB7C Q37135548-4F572FED-0081-4184-94D2-EB5DB6091139 Q37206262-AE5383D2-AAD7-497D-954A-3837A83D1F5C Q37280979-66CBFB25-3614-4AD5-99EE-D7C67F320042 Q37343069-468EFBAB-82F1-498D-ACDF-85735654610A Q37347220-4CFAAD4B-9F0F-40C2-BFFB-E7A79FF29024 Q37623616-A98E85D4-68D8-4DF6-9A48-F6E627B76E4E Q37691267-F92A8501-D4A9-4159-9E21-54A8519D8DB1 Q37698240-F7FB192A-1F0C-47D7-9DD2-9A1267F11BDB Q37806123-A91F036B-82C2-410D-925C-ED87A599A591 Q37818319-6C849BDB-F61F-452C-916C-EE61349B5E06

P2860

Proteomic analysis of multiple sclerosis cerebrospinal fluid

http://www.wikidata.org/entity/Q28269026

description

2004 nî lūn-bûn

@nan

2004 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Proteomic analysis of multiple sclerosis cerebrospinal fluid

@ast

Proteomic analysis of multiple sclerosis cerebrospinal fluid

@en

Proteomic analysis of multiple sclerosis cerebrospinal fluid

@nl

type

label

Proteomic analysis of multiple sclerosis cerebrospinal fluid

@ast

Proteomic analysis of multiple sclerosis cerebrospinal fluid

@en

Proteomic analysis of multiple sclerosis cerebrospinal fluid

@nl

prefLabel

Proteomic analysis of multiple sclerosis cerebrospinal fluid

@ast

Proteomic analysis of multiple sclerosis cerebrospinal fluid

@en

Proteomic analysis of multiple sclerosis cerebrospinal fluid

@nl

P1433

Q28269026-146DCA5E-A52E-4221-B9FA-0636B73F4AAD

P1476

Q28269026-F7B64F25-4AE4-4AA2-BDA5-E3836B85CA03

P2093

Q28269026-091D65B1-754B-4517-A667-CFDC4AE7CCA1

Q28269026-35010D5B-8777-41C6-9BE7-6E3AB23B77AE

Q28269026-88D18B5E-395F-42CF-97DF-07C2C93FB73D

Q28269026-B9027FBF-9DA2-4385-B2C4-98315DCF1531

Q28269026-E5CF70C4-F484-4633-A127-6E69AA3A4A7C

Q28269026-FCC18EC5-DECF-4D86-BAA0-3A81B5617191

P2860

Q28269026-134B2CF2-A639-486B-9EFE-7B8946E2C696

Q28269026-3F8115E7-71F8-4372-B471-5B81646A60DB

Q28269026-5D09474B-9688-4DF5-A560-81AEE47B519C

Q28269026-64395EE0-2440-4385-AC40-709A1317D3F3

Q28269026-95E191E1-88B3-48F8-9FC5-4237489EA0AC

Q28269026-9BA9A165-4D89-4E00-83DA-EC2F7628D513

Q28269026-9E8CC757-1E31-496E-BD6B-D665B50E3087

Q28269026-A4C993D5-1E07-491F-A342-0D9963F33B23

Q28269026-E0FA6B4A-622A-466F-8CCB-D120DA94DBE8

Q28269026-E5D419E1-5E67-4B1F-A678-3A35E612CFF0

P304

Q28269026-41A6C237-D56A-4FA4-AFFE-D6BD2D239210

P31

Q28269026-5288E63D-FCBE-4418-8557-44B3310FBF85

P356

Q28269026-50D1C9D3-53FE-4792-87D5-26C2275AF5A5

P407

Q28269026-96959268-EB04-4D32-A7C9-0BE1A9CFBA9B

P433

Q28269026-43F29920-9DF7-44F9-AA7D-C2CE81024B77

P478

Q28269026-DB3470B3-ABC0-4985-B6E8-3E56C319882F

P50

Q28269026-8BF4D7EF-07F3-4EEB-B75C-F85D5B10875F

P577

Q28269026-2C6A03BF-95D1-4511-BF9F-E4E58996593D

P698

Q28269026-C1406377-7BC9-40AB-A096-76C055B9E993

P921

Q28269026-4A851532-89C2-4956-AD02-9CD668E7753F

Q28269026-4D38C836-E143-41C7-BF24-0E612CA937F6

P356

1352458504MS1023OA

P1433

Multiple Sclerosis Journal

P1476

Proteomic analysis of multiple sclerosis cerebrospinal fluid

@en

P2093

B N Hammack

http://www.w3.org/2001/XMLSchema#string

D H Gilden

http://www.w3.org/2001/XMLSchema#string

G P Owens

http://www.w3.org/2001/XMLSchema#string

M P Burgoon

http://www.w3.org/2001/XMLSchema#string

M W Duncan

http://www.w3.org/2001/XMLSchema#string

S W Hunsucker

http://www.w3.org/2001/XMLSchema#string

P2860

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

Probability-based protein identification by searching sequence databases using mass spectrometry data

SPARC, a matricellular glycoprotein with important biological functions

Multiple sclerosis in the Faroe Islands: I. Clinical and epidemiological features

Towards a high resolution separation of human cerebrospinal fluid.

Analysis of the human lumbar cerebrospinal fluid proteome.

Progress with gene-product mapping of the Mollicutes: Mycoplasma genitalium.

The genetics of susceptibility to multiple sclerosis.

The search for virus in multiple sclerosis brain.

Multiple sclerosis: an important role for post-translational modifications of myelin basic protein in pathogenesis.

P304

245-260

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1191/1352458504MS1023OA

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

P577

2004-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15222687

http://www.w3.org/2001/XMLSchema#string

P921

cerebrospinal fluid

multiple sclerosis